Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature.
about
Antibody drug-conjugates targeting the tumor vasculature: Current and future developmentsA novel method of differential gene expression analysis using multiple cDNA libraries applied to the identification of tumour endothelial genes.Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors.Delivery of lipoplexes for genotherapy of solid tumours: role of vascular endothelial cells.Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases.Hypoxic tumor cell death and modulation of endothelial adhesion molecules in the regression of granulocyte colony-stimulating factor-transduced tumors.E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy.Psi- vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors.Tumour angiogenesis, vascular biology and enhanced drug delivery.Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies.Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate.Inhibition of angiogenesis and tumour growth by VEGF121-toxin conjugate: differential effect on proliferating endothelial cells.Specific binding of TES-23 antibody to tumour vascular endothelium in mice, rats and human cancer tissue: a novel drug carrier for cancer targeting therapy.Antiangiogenic therapy in brain tumors.Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.Radionuclide carriers for targeting of cancer.Tumour vascular disrupting agents: combating treatment resistance.Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer.Targeted drug delivery strategies to treat lung metastasis.Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours.Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation.Endothelial cells expressing an inflammatory phenotype are lysed by superantigen-targeted cytotoxic T cells.Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.Radioimmunotherapy with astatine-211 using chimeric monoclonal antibody U36 in head and neck squamous cell carcinoma.Tumour vasculature--a potential therapeutic target.MCAM and LAMA4 Are Highly Enriched in Tumor Blood Vessels of Renal Cell Carcinoma and Predict Patient Outcome.Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma.Antitumor effect of the idiotypic cascade induced by an antibody encapsulated in poly(d,l-lactide-co-glycolide) microspheres.Emerging therapeutic targets in angiogenesis
P2860
Q28270261-AF83661F-12BB-4064-911D-990231CE3026Q33327177-A7EC7060-56C8-4474-984A-26CCC46F500AQ34068188-E292A15B-B9CD-4CD2-94D4-44C3CD340C54Q34143913-2D257907-7A5C-4C69-A649-2C65A72A6EB0Q34756781-0BFA0DF3-45AD-4D81-9051-FB9EA8610F46Q35774179-EDEFCB9A-0CCF-4A73-9863-AAB163CF5531Q35850215-BCC2C0DD-EF37-47C8-AF29-B8F1249746B3Q35890587-40533411-0674-4A8A-852D-50818D007E35Q35931998-418AA541-383C-44DC-A87E-0CB5D59B4D62Q36141279-AEEFE4F8-8BE4-45FA-8AC8-9F88D8E78732Q36421314-47ADAFBF-09D0-4433-BF65-001F05BC08F6Q36621993-EB14EC24-67D0-428B-8558-65E6A924B1ADQ36641057-A1959CF0-1FCB-449E-905E-3C3F96770B8EQ37129915-93825CDB-68AD-42AE-A877-2E0DB16174D1Q37159509-CC8994D5-E9B2-43D3-861F-2D6B6D5120A1Q37237705-1D5DDD77-7DB6-408C-B1AB-C120602F686DQ37280244-EAF91932-E841-4B83-9683-45652FC8F820Q37520289-297B6E0A-19BE-47A2-8CEB-37F058399E58Q37575499-883DF6AC-63C9-4191-B59A-418CB575170EQ37610628-CE0A0910-FA03-4C55-8C15-BD9C96876131Q39205186-68582FB5-7641-4915-87D2-31F13F500D7DQ39505993-FF1EA0B6-893F-4278-9B38-E45CF8EF552DQ39517637-F668CD56-2C1E-4664-B447-8E3AE7FB9474Q40144418-C949DDE1-182F-4BF8-9660-FBEEC876C8DCQ40403280-3FA9E341-9AAC-45B1-A04E-F968593A04C4Q41990849-33A0FF59-1123-4C2F-B2EE-105ACEDEB876Q47317744-5E5E9E64-DA75-44F1-984E-59DEB645F08CQ55154679-D00B8D78-72A6-4C90-9603-7DC47E4605F2Q58212229-125DDBD4-3662-4FCC-80A7-31A1C6D406CD
P2860
Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Eradication of large solid tum ...... ted against tumor vasculature.
@ast
Eradication of large solid tum ...... ted against tumor vasculature.
@en
type
label
Eradication of large solid tum ...... ted against tumor vasculature.
@ast
Eradication of large solid tum ...... ted against tumor vasculature.
@en
prefLabel
Eradication of large solid tum ...... ted against tumor vasculature.
@ast
Eradication of large solid tum ...... ted against tumor vasculature.
@en
P2860
P356
P1476
Eradication of large solid tum ...... ted against tumor vasculature.
@en
P2093
F J Burrows
P E Thorpe
P2860
P304
P356
10.1073/PNAS.90.19.8996
P407
P577
1993-10-01T00:00:00Z